Extract from the Register of European Patents

EP About this file: EP1636185

EP1636185 - NOVEL CRYSTALLINE FORMS OF PERINDOPRIL ERBUMINE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.11.2012
Database last updated on 08.04.2026
Most recent event   Tooltip16.07.2021Change - lapse in a contracting statepublished on 18.08.2021  [2021/33]
Applicant(s)For all designated states
Les Laboratoires Servier
35, rue de Verdun
92284 Suresnes Cedex / FR
[2012/24]
Former [2007/25]For all designated states
Les Laboratoires Servier
22, rue Garnier
92278 Neuilly sur Seine / FR
Former [2006/12]For all designated states
Azad Pharmaceutical Ingredients AG
Friedbergstrasse 68
8200 Schaffhausen / CH
Inventor(s)01 / STRÄSSLER, Christoph
Unterfeldstrasse 17
CH-8050 Zürich / CH
02 / LELLEK, Vit
Schauenbergstr. 8
CH-8046 Zürich / CH
03 / FÄSSLER, Roger
Spitzacker 8
CH-8246 Langwiesen / CH
 [2006/12]
Representative(s)Braun, André jr., et al
Braunpat Braun Eder AG
Reussstrasse 22
Postfach
4015 Basel / CH
[N/P]
Former [2009/31]Braun, André jr., et al
Braunpat Braun Eder AG Reussstrasse 22 Postfach
4015 Basel / CH
Former [2006/12]Braun, André jr., et al
Braunpat Braun Eder AG Reussstrasse 22
4054 Basel / CH
Application number, filing date04737029.118.06.2004
[2006/12]
WO2004CH00374
Priority number, dateCH11090324.06.2003         Original published format: CH 110903
[2006/12]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2004113293
Date:29.12.2004
Language:DE
[2004/53]
Type: A1 Application with search report 
No.:EP1636185
Date:22.03.2006
Language:DE
The application published by WIPO in one of the EPO official languages on 29.12.2004 takes the place of the publication of the European patent application.
[2006/12]
Type: B1 Patent specification 
No.:EP1636185
Date:11.01.2012
Language:DE
[2012/02]
Search report(s)International search report - published on:EP29.12.2004
ClassificationIPC:C07D209/42
[2006/12]
CPC:
C07D209/42 (EP,KR,US); A61K31/404 (KR); A61P43/00 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07B2200/13 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/12]
Extension statesAL06.12.2005
HR06.12.2005
LT06.12.2005
LV06.12.2005
MK06.12.2005
TitleGerman:NEUE KRISTALLINE FORMEN VON PERINDOPRIL ERBUMINE[2006/12]
English:NOVEL CRYSTALLINE FORMS OF PERINDOPRIL ERBUMINE[2006/12]
French:NOUVELLES FORMES CRISTALLINES DE PERINDOPRIL ERBUMINE[2006/12]
Entry into regional phase06.12.2005National basic fee paid 
06.12.2005Designation fee(s) paid 
06.12.2005Examination fee paid 
Examination procedure06.12.2005Examination requested  [2006/12]
25.03.2008Despatch of a communication from the examining division (Time limit: M06)
18.09.2008Reply to a communication from the examining division
01.07.2011Date of oral proceedings
12.07.2011Minutes of oral proceedings despatched
28.07.2011Communication of intention to grant the patent
09.11.2011Fee for grant paid
09.11.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.03.2008
Opposition(s)12.10.2012No opposition filed within time limit [2012/51]
Fees paidRenewal fee
06.12.2005Renewal fee patent year 03
14.06.2007Renewal fee patent year 04
28.03.2008Renewal fee patent year 05
04.01.2010Renewal fee patent year 06
30.06.2010Renewal fee patent year 07
30.06.2011Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.06.200906   M06   Fee paid on   04.01.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipTR18.06.2012
[2021/33]
Former [2017/52]TR18.06.2012
Former [2014/12]TR18.06.2012
HU19.06.2012
Former [2013/22]HU19.06.2012
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.